Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Oct 27 - Nov 1
For patients with BMI 35 kg/m (regardless of comorbidities) or BMI 30-34.9 kg/m with metabolic disease, bariatric surgery consultation may be appropriate, according to 2022 American Society for Metabolic and Bariatric Surgery guidelines
Truveta reported in September 2025 that 6.5% of all prescriptions recently written were for a GLP-1 drug and that 2.5 million patients had filled 12.2 million prescriptions since 2017
the product catalog extends well beyond GLP-1s to include hormone therapy, peptides, NAD+ injections, sexual health, dermatology, mental health, and nutritional formulations
Impaired vitamin B12 metabolic status in healthcare workers occupationally exposed to nitrous oxide
Food and Drug Administration (FDA) approved Wegovy as the first treatment to reduce the risk of serious heart problems in overweight and obese adults
US$ 21.76
US$ 23.44
US$ 29.40
US$ 21.92
